ADMA Biologics ADMA Stock Issued During Period, Value, Stock Options Exercised
Stock Issued During Period, Value, Stock Options Exercised at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's stock issued during period, value, stock options exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ADMA Biologics's stock issued during period, value, stock options exercised?
- ADMA Biologics (ADMA) reported stock issued during period, value, stock options exercised of $588K in Q1 2026.
- How has ADMA Biologics's stock issued during period, value, stock options exercised changed year-over-year?
- ADMA Biologics's stock issued during period, value, stock options exercised increased by 482.2% year-over-year, from $101K to $588K.
- What is the long-term trend for ADMA Biologics's stock issued during period, value, stock options exercised?
- Over 2 years (2023 to 2025), ADMA Biologics's stock issued during period, value, stock options exercised has grown at a 64.4% compound annual growth rate (CAGR), from $1.1M to $2.98M.
- What does stock issued during period, value, stock options exercised mean?
- This represents the cash proceeds received by the company from the exercise of employee or director stock options. It indicates the conversion of equity-based incentives into capital and the resulting increase in outstanding shares.